Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric Study Requests Would Benefit From Input On Trial Design – Cmte.

Executive Summary

FDA hopes that internal process improvements will result in "more clever" requests to companies for pediatric studies under the Best Pharmaceuticals for Children Act

You may also be interested in...



Senate HELP Committee Leadership: Sizing Up The Candidates

Sen. Chris Dodd has a relatively limited record in pharmaceutical legislation - especially in comparison to the late Sen. Ted Kennedy - but his initiatives include establishing incentives for pediatric drug development and supporting increased government oversight in the areas of drug safety and direct-to-consumer advertising

Senate HELP Committee Leadership: Sizing Up The Candidates

Sen. Chris Dodd has a relatively limited record in pharmaceutical legislation - especially in comparison to the late Sen. Ted Kennedy - but his initiatives include establishing incentives for pediatric drug development and supporting increased government oversight in the areas of drug safety and direct-to-consumer advertising

Senate HELP Committee Leadership: Sizing Up The Candidates

Regardless who is chosen as chairman, the committee will undoubtedly feel in the near-term the absence of a champion of federal health programs - one who is both forceful in demeanor and expert in the detailed workings and policy history of a variety of initiatives.

Related Content

UsernamePublicRestriction

Register

OM013214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel